NCT00405860View on ClinicalTrials.gov

CellCept in p-ANCA Vasculitis

PHASE1CompletedINTERVENTIONAL
Enrollment

18

Participants

Timeline

Start Date

December 31, 2002

Primary Completion Date

July 31, 2008

Study Completion Date

July 31, 2008

Conditions
MPO-ANCA VasculitisMicroscopic Polyangiitis
Interventions
DRUG

CellCept (mycophenolate mofetil)

Trial Locations (1)

55905

Mayo Clinic, Rochester

Sponsors

Lead Sponsor

Mayo Clinic
All Listed Sponsors
collaborator

Roche Pharma AG

INDUSTRY

lead

Mayo Clinic

OTHER

NCT00405860 - CellCept in p-ANCA Vasculitis | Biotech Hunter | Biotech Hunter